21 February 2020 

Quintis CEO Succession 

The Board of Quintis is pleased to announce that Richard Henfrey has been appointed to succeed Julius Matthys as Chief Executive Officer of the Company. Mr Matthys will remain with the Company as a Non-Executive Director.

Mr Henfrey has extensive executive experience, most recently comprising of 10 years at ASX-200 health supplements business Blackmores, which culminated in him being elevated to the position of Chief Executive Officer. As Blackmores’ Chief Operating Officer, he was responsible for overseeing a significant overhaul of its supply chain and distribution network in order to facilitate an increased push into the Asian market, particularly in China. His successful implementation of this strategy contributed to Blackmores’ net profit after tax for the 2016 financial year increasing by 115 per cent.

This experience and track record is attractive to Quintis, as it builds on the positive market development that has already been achieved in preparation for far larger harvests in the next few years.

 

Richard Henfrey – Biography

Richard recently concluded 10 years’ experience on the executive team of major publicly listed vitamin supplements business Blackmores, culminating in his appointment as CEO.

Richard drove major change at Blackmores, particularly the significant move to become a manufacturer for the first time in the company’s history, and he oversaw the doubling of Blackmores supply chain capacity to meet extraordinary and sudden demand from China. His successful implementation of this strategy contributed to Blackmores’ net profit after tax for the 2016 financial year increasing by 115 per cent.

He has also worked in a managerial capacity at another prominent Australian business, Telstra, where he led a national specialist sales team of 160 sales professionals. He started his professional career in the UK telco industry.

Richard has notably served as Board President of peak industry body Complementary Medicines Australia, and is a graduate of the University of Cambridge, holding a Master of Arts degree in Natural Sciences, specialising in genetics and molecular/cell biology.